X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (955) 955
female (862) 862
ca-125 antigen - blood (461) 461
middle aged (426) 426
oncology (410) 410
adult (381) 381
index medicus (359) 359
ovarian cancer (336) 336
aged (331) 331
ovarian neoplasms - immunology (322) 322
cancer (271) 271
ca-125 (231) 231
biomarkers, tumor - blood (224) 224
carcinoma (204) 204
ca125 (200) 200
ca-125 antigen - immunology (185) 185
obstetrics & gynecology (171) 171
ovarian neoplasms - pathology (166) 166
ovarian neoplasms - diagnosis (159) 159
prognosis (158) 158
ovarian neoplasms - blood (154) 154
male (147) 147
diagnosis (143) 143
sensitivity and specificity (134) 134
aged, 80 and over (132) 132
ca 125 (131) 131
biomarkers (125) 125
animals (123) 123
ca-125 antigen - analysis (122) 122
monoclonal-antibody (118) 118
neoplasm staging (109) 109
expression (107) 107
tumors (107) 107
immunology (105) 105
ca-125 antigen - metabolism (101) 101
research (100) 100
retrospective studies (100) 100
chemotherapy (99) 99
mice (99) 99
predictive value of tests (99) 99
ovarian neoplasms - therapy (97) 97
immunohistochemistry (96) 96
analysis (91) 91
antigens (90) 90
ovarian neoplasms - drug therapy (90) 90
antigen (86) 86
ovarian-cancer (80) 80
proteins (80) 80
survival (78) 78
roc curve (76) 76
carcinoembryonic antigen (74) 74
women (73) 73
antigens, tumor-associated, carbohydrate - blood (70) 70
biomarkers, tumor - analysis (69) 69
membrane proteins - blood (68) 68
ovarian neoplasms - surgery (68) 68
enzyme-linked immunosorbent assay (67) 67
prospective studies (67) 67
reproductive biology (67) 67
care and treatment (66) 66
pathology (66) 66
treatment outcome (66) 66
diagnosis, differential (65) 65
endometriosis (65) 65
research article (64) 64
surgery (64) 64
antibodies, monoclonal - immunology (63) 63
case-control studies (63) 63
adolescent (62) 62
tumor-markers (62) 62
ca-19-9 antigen - blood (61) 61
cancer research (61) 61
follow-up studies (59) 59
tumor markers (59) 59
health aspects (57) 57
immunotherapy (56) 56
risk factors (56) 56
serum (56) 56
benign (55) 55
medicine (55) 55
ovarian carcinoma (55) 55
ovarian neoplasms - metabolism (53) 53
serum ca-125 (53) 53
survival analysis (53) 53
biomedicine (51) 51
carcinoembryonic antigen - blood (51) 51
ovarian neoplasms - diagnostic imaging (50) 50
ovarian neoplasms - mortality (50) 50
recurrence (50) 50
endocrine system diseases (49) 49
patients (49) 49
ca-125 antigen - genetics (48) 48
multidisciplinary sciences (48) 48
carcinoma, ovarian epithelial (47) 47
time factors (47) 47
cell line, tumor (46) 46
young adult (46) 46
adenocarcinoma (45) 45
markers (45) 45
pregnancy (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (928) 928
Polish (22) 22
Chinese (13) 13
French (10) 10
Japanese (9) 9
Russian (5) 5
German (4) 4
Danish (3) 3
Italian (3) 3
Spanish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Icelandic (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Balachandran, Vinod P and Luksza, Marta and Zhao, Julia N and Makarov, Vladimir and Moral, John Alec and Remark, Romain and Herbst, Brian and Askan, Gokce and Bhanot, Umesh and Senbabaoglu, Yasin and Wells, Daniel K and Cary, Charles Ian Ormsby and Grbovic-Huezo, Olivera and Attiyeh, Marc and Medina, Benjamin and Zhang, Jennifer and Loo, Jennifer and Saglimbeni, Joseph and Abu-Akeel, Mohsen and Zappasodi, Roberta and Riaz, Nadeem and Smoragiewicz, Martin and Kelley, Z. Larkin and Basturk, Olca and Gönen, Mithat and Levine, Arnold J and Allen, Peter J and Fearon, Douglas T and Merad, Miriam and Gnjatic, Sacha and Iacobuzio-Donahue, Christine A and Wolchok, Jedd D and DeMatteo, Ronald P and Chan, Timothy A and Greenbaum, Benjamin D and Merghoub, Taha and Leach, Steven D and Australian Pancreatic Canc Genom and Garvan Institute of Medical Research and Bankstown Hospital and St Vincent’s Hospital and Royal Adelaide Hospital and Royal North Shore Hospital and Envoi Pathology and QIMR Berghofer Medical Research Institute and Prince of Wales Hospital and University of Melbourne, Centre for Cancer Research and University of Queensland, Institute for Molecular Bioscience and Royal Prince Alfred Hospital, Chris O’Brien Lifehouse and Princess Alexandria Hospital and Fremantle Hospital and Liverpool Hospital and Austin Hospital and University of Glasgow and Johns Hopkins Medical Institutes and Flinders Medical Centre and Westmead Hospital and St John of God Healthcare and ARC-Net Centre for Applied Research on Cancer and Australian Pancreatic Cancer Genome Initiative
Nature, ISSN 0028-0836, 11/2017, Volume 551, Issue 7681, pp. S12 - S16
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2017, Volume 114, Issue 46, pp. E9942 - E9951
Immunotherapies, particularly checkpoint inhibitors, have set off a revolution in cancer therapy by releasing the power of the immune system. However, only... 
Mesothelin | Mucin 16 | Immunotherapy | Immunopeptidome | Ovarian cancer | SURVIVAL | ovarian cancer | mucin 16 | MULTIDISCIPLINARY SCIENCES | IMMUNE PRIVILEGE | immunopeptidome | TUMOR | ANTIGENS | CANCER-IMMUNOTHERAPY | IDENTIFICATION | mesothelin | ADVANCED MELANOMA | immunotherapy | EXPRESSION | T-CELLS | Membrane Glycoproteins - analysis | Kallikreins - immunology | CA-125 Antigen - immunology | Galectin 1 - immunology | Membrane Glycoproteins - metabolism | Humans | Vaccination | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Neoplasms, Glandular and Epithelial - metabolism | Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology | Neoplasms, Glandular and Epithelial - immunology | Histocompatibility Antigens Class I - metabolism | Female | Histocompatibility Antigens Class II - metabolism | Ovarian Neoplasms - metabolism | Membrane Glycoproteins - immunology | HLA-DR Antigens - metabolism | Neoplasms, Glandular and Epithelial - pathology | GPI-Linked Proteins - immunology | Histocompatibility Antigens Class I - immunology | Membrane Proteins - immunology | Antigen Presentation - immunology | Membrane Glycoproteins - genetics | Histocompatibility Antigens Class II - immunology | Carcinoma, Ovarian Epithelial | Ligands | HLA-DR Antigens - immunology | Ovarian Neoplasms - immunology | Physiological aspects | Antigens | Peptides | Health aspects | Biological Sciences | PNAS Plus
Journal Article
Molecular Cancer, ISSN 1476-4598, 05/2014, Volume 13, Issue 1, pp. 129 - 129
Over three decades have passed since the first report on the expression of CA125 by ovarian tumors. Since that time our understanding of ovarian cancer biology... 
Cancer biomarker | MUC16 | CA125 | Metastasis | Natural killer cells | Immunesupression | Ovarian cancer | PELVIC MASS | ISOBM TD-1 WORKSHOP | CA 125 | PRIMARY PERITONEAL CANCER | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCLONAL-ANTIBODY MORAB-009 | OCULAR SURFACE EPITHELIA | EPITHELIAL OVARIAN-CANCER | WISH CELL-LINE | ONCOLOGY | ANTIGEN CA125 | ANTIIDIOTYPE INDUCTION THERAPY | CA-125 Antigen - immunology | Prognosis | CA-125 Antigen - genetics | Humans | Ovarian Neoplasms - pathology | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Killer Cells, Natural - pathology | Neoplasm Metastasis | Immunotherapy | Killer Cells, Natural - immunology | Female | Biomarkers, Tumor - antagonists & inhibitors | Gene Expression | Membrane Proteins - genetics | Ovarian Neoplasms - diagnosis | Membrane Proteins - immunology | Clinical Trials as Topic | Disease Progression | Proteins - immunology | Proteins - genetics | Membrane Proteins - antagonists & inhibitors | Ovarian Neoplasms - therapy | Biomarkers, Tumor - genetics | Biomarkers, Tumor - immunology | Ovarian Neoplasms - immunology | Antimitotic agents | Usage | Care and treatment | Oncology, Experimental | Mucins | Development and progression | Research | Antineoplastic agents | Cancer | Antigenic determinants | Antigens | Flow cytometry | Gynecology | Mortality | Grants | Medical screening | Studies | Ultrasonic imaging | Algorithms | Womens health | Biomarkers
Journal Article
Journal Article
Nature Biotechnology, ISSN 1087-0156, 08/2008, Volume 26, Issue 8, pp. 925 - 932
Journal Article
Journal Article
Chemical communications (Cambridge, England), ISSN 1359-7345, 02/2014, Volume 50, Issue 11, pp. 1344 - 1346
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 13, pp. 3453 - 3460
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 02/2018, Volume 27, Issue 2, pp. 183 - 192
Background: Tumor-directed circulating autoantibodies (AAb) are a well-established feature of many solid tumor types, and are often observed prior to clinical... 
CELLS | IGA | CYSTADENOFIBROMAS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | TUMOR-ASSOCIATED ANTIGENS | ONCOLOGY | SECRETORY IMMUNE-SYSTEM | GENITAL TRACTS | FALLOPIAN-TUBE | FEMALE REPRODUCTIVE-TRACT | PROTEIN ARRAYS | EXPRESSION |